Recent AML-related studies have demonstrated that MCL1 interacts with Hexokinase 2 (HK2) on the outer mitochondrial membrane, inducing glycolysis and mitochondrial oxidative phosphorylation (OXPHOS) and thereby endowing cell metabolic plasticity, which may promote resistance to therapy [9]. Here, MCL1 is linked to acute myeloid leukemia.